Intraoperative electron beam radiotherapy (IOERT) in the management of recurrent ovarian malignancies

International Journal of Gynecological Cancer

Volumn 21, Issue 7, 2011, Pages 1225-1231

  Barney, Brandon M ^a   Petersen, Ivy A ^a   Dowdy, Sean C ^a   Bakkum Gamez, Jamie N ^a   Haddock, Michael G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Intraoperative radiation therapy; Local disease relapse; Ovarian cancer; Surgical cytoreduction

Indexed keywords

ABSCESS; ADULT; AGED; ARTICLE; BLEEDING; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC DIARRHEA; CLINICAL ARTICLE; CYSTITIS; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM FISTULA; DISEASE CONTROL; DISEASE FREE INTERVAL; ELECTRON THERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; FRACTURE; GASTROINTESTINAL OBSTRUCTION; HUMAN; INTRAOPERATIVE PERIOD; LYMPHEDEMA; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; SURVIVAL; URETER OBSTRUCTION; CARCINOMA; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; MORTALITY; OVARY TUMOR; PEROPERATIVE CARE; PROGNOSIS; TUMOR RECURRENCE; UNITED STATES;

ADULT; AGED; CARCINOMA; FEMALE; HUMANS; INTRAOPERATIVE CARE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; UNITED STATES;

EID: 84856073969     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822c750d     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IVovarian cancer. N Engl J Med. 1996;334:1-6. (Pubitemid 26012496)
3. Muggia FM, Braly PS, Brady MF, et al. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study. J Clin Oncol. 2000;18:106-115. (Pubitemid 30036343)
4. Rose PG, Nerenstone S, Brady MF, et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med. 2004;351:2489-2497.
5. Spriggs DR, Brady MF, Vaccarello L, et al. Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:4466-4471. (Pubitemid 350013853)
6. Aletti GD, Podratz KC, Cliby WA, et al. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment. Gynecol Oncol. 2009;112:22-27.
7. Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34-43. (Pubitemid 43048949)
8. Dembo AJ, . Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience. Cancer. 1985:55:2285-2290. (Pubitemid 15119197)
9. Dembo AJ. Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys. 1992;22:835-845.
10. Donato ML, Aleman A, Champlin RE, et al. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004;33:1219-1224. (Pubitemid 38961480)
11. Sorbe B, . Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer. 2003;13:278-286. (Pubitemid 38222574)
12. Varia MA, Stehman FB, Bundy BN, et al. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. J Clin Oncol. 2003;21:2849-2855. (Pubitemid 46621832)
13. Young RC, Brady MF, Nieberg RK, et al. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin-a gynecologic oncology group study. J Clin Oncol. 2003;21:4350-4355. (Pubitemid 46621811)
14. Verheijen RH, Massuger LF, Benigno BB, et al. Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission. J Clin Oncol. 2006;24:571-578. (Pubitemid 46655592)
15. van der Burg ME, van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med. 1995;332:629-634.
16. Chiara S, Conte P, Franzone P, et al. High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol. 1994;17:72-76. (Pubitemid 24062739)
17. Bruzzone M, Repetto L, Chiara S, et al. Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol Oncol. 1990;38:392-395. (Pubitemid 20362563)
18. Lambert HE, Rustin GJ, Gregory WM, et al. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study. J Clin Oncol. 1993;11:440-448. (Pubitemid 23071039)
19. Lawton F, Luesley D, Blackledge G, et al. A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group Trial II. Clin Oncol (R Coll Radiol). 1990;2:4-9.
20. Pickel H, Lahousen M, Petru E, et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol. 1999;72:215-219. (Pubitemid 29093778)
21. Haddock MG, Petersen IA, Pritchard D, et al. IORT in the management of extremity and limb girdle soft tissue sarcomas. Front Radiat Ther Oncol. 1997;31:151-152.
22. Haddock MG, Petersen IA, Webb MJ, et al. IORT for locally advanced gynecological malignancies. Front Radiat Ther Oncol. 1997;31:256-259.
23. Miller RC, Haddock MG, Gunderson LL, et al. Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas Dis Esophagus. 2006;19:487-495. (Pubitemid 44644687)
24. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2002;52:469-475. (Pubitemid 34170851)
25. Haddock MG, Miller RC, Nelson H, et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2011;79:143-150.